查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1572471

離心血泵市場、機會、成長動力、產業趨勢分析與預測，2024-2032

Centrifugal Blood Pumps Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 102 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023 年，全球離心血泵市場價值約為 9,510 萬美元，預計 2024 年至 2032 年複合年成長率為 5.3%。人口老化、肥胖、高血壓和糖尿病等因素正在增加心臟衰竭和冠狀動脈疾病的發生率。例如，國家醫學圖書館2023 年的一項研究強調，約670 萬美國成年人患有心臟衰竭(HF)，預計到2030 年這一數字將增至850 萬。 ，四分之一的美國人患有心臟衰竭(HF)。離心血泵對於治療嚴重心臟衰竭病例和複雜的心臟手術至關重要，可改善患者的治療效果並推動市場成長。

技術進步在市場擴張中發揮了至關重要的作用。磁浮技術等創新技術可以最大限度地減少機械磨損並提高泵浦的可靠性，已經改變了整個產業。此外，先進的監測和控制系統的整合可以即時了解幫浦的性能和患者狀況，從而提高安全性和有效性。這些進步不僅提高了離心血泵的性能和可靠性，還擴大了其在急性和慢性心血管護理中的應用，推動市場成長。

離心血泵產業根據產品類型、最終用途和地區進行分類。

市場分為電氣和機械領域，預計到 2032 年，電氣領域將達到 1.138 億美元。這些幫浦配備了尖端技術，可以進行即時調整併提高效率，特別是在複雜的外科手術或重症監護期間。此外，電子和小型化的進步為更複雜、更可靠的電動幫浦鋪平了道路，進一步提高了它們的市場佔有率。

分為短期和長期支持申請，長期支持部分在 2023 年將達到 3,710 萬美元。離心泵在體外膜氧合（ECMO）和心室輔助裝置（VAD）等先進療法中的使用不斷增加，增強了該細分市場的實力。 ECMO 系統對於心臟和呼吸支援至關重要，需要長期幫浦解決方案才能持續運作。同樣，VAD 透過提高泵血效率來幫助嚴重心臟衰竭患者，大大受益於專為長期使用而設計的離心泵的耐用性和效率。

預計到 2032 年，美國離心血泵市場將達到 5,840 萬美元。隨著這些情況變得越來越普遍，對先進醫療設備（尤其是離心血泵）的需求激增，突顯了它們在管理嚴重心臟問題和支持心臟手術患者方面的重要性。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 心血管疾病盛行率不斷上升
      • 離心血泵的技術進步
      • 心血管研究和開發的投資不斷增加
    • 產業陷阱與挑戰
      • 設備成本高
      • 嚴格的監管場景
  • 成長潛力分析
  • 監管環境
  • 技術景觀
    • 核心技術
    • 鄰近技術
  • 未來市場趨勢
  • 差距分析
  • 波特的分析
  • 杵分析

第 4 章：競爭格局

  • 介紹
  • 公司市佔率分析
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章：市場估計與預測：按產品類型，2021 - 2032

  • 主要趨勢
  • 電力
  • 機械的

第 6 章：市場估計與預測：按應用分類，2021 - 2032

  • 主要趨勢
  • 短期支持
  • 長期支持

第 7 章：市場估計與預測：按最終用途，2021 - 2032 年

  • 主要趨勢
  • 醫院
  • 門診手術中心
  • 專科診所
  • 其他最終用戶

第 8 章：市場估計與預測：按地區分類，2021 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 9 章：公司簡介

  • Abbott Laboratories
  • Braile Biomedica
  • Getinge AB
  • Hugo Sachs Elektronik
  • LivaNova PLC
  • Medtronic plc
  • Senko Medical Instrument Mfg. Co., Ltd.
  • Spectrum Medical
  • Terumo Corporation
簡介目錄
Product Code: 10857

The Global Centrifugal Blood Pumps Market was valued at approximately USD 95.1 million in 2023 and is projected to grow at 5.3% CAGR from 2024 to 2032. The rising prevalence of cardiovascular diseases (CVDs) significantly drives the market. Factors like an aging population, obesity, hypertension, and diabetes are increasing the incidence of heart failure and coronary artery disease. For instance, a 2023 study from the National Library of Medicine highlighted that about 6.7 million U.S. adults have heart failure (HF), a number projected to rise to 8.5 million by 2030. With a lifetime risk of 24%, it's estimated that one in four individuals will face heart failure at some point. Centrifugal blood pumps are pivotal in managing severe heart failure cases and intricate cardiac procedures, leading to improved patient outcomes and propelling market growth.

Technological advancements have played a crucial role in market expansion. Innovations like magnetic levitation technology, which minimizes mechanical wear and boosts pump reliability, have transformed the industry. Furthermore, the integration of advanced monitoring and control systems offers real-time insights into pump performance and patient conditions, enhancing safety and efficacy. These advancements not only elevate the performance and reliability of centrifugal blood pumps but also expand their application in both acute and chronic cardiovascular care, driving market growth.

The centrifugal blood pumps industry is classified based on product type, end-use, and region.

Divided into electrical and mechanical segments, the market forecasts the electrical segment to reach USD 113.8 million by 2032. Valued for their precision control and superior performance, electrical centrifugal blood pumps are becoming increasingly sought after in contemporary medical environments. These pumps, equipped with cutting-edge technology, allow real-time adjustments and heightened efficiency, especially during intricate surgical procedures or in critical care. Moreover, advancements in electronics and miniaturization are paving the way for more sophisticated and dependable electrical pumps, further boosting their market presence.

Segmented into short-term and long-term support applications, the long-term support segment leading with USD 37.1 million in 2023. This dominance stems from the rising demand for durable solutions to address chronic cardiovascular issues. The segment's strength is bolstered by the growing utilization of centrifugal pumps in advanced therapies like extracorporeal membrane oxygenation (ECMO) and ventricular assist devices (VADs). ECMO systems, vital for cardiac and respiratory support, necessitate long-term pump solutions for consistent operation. Likewise, VADs, aiding severe heart failure patients by enhancing blood pumping efficiency, greatly benefit from the durability and efficiency of centrifugal pumps designed for prolonged use.

The U.S. Centrifugal Blood Pumps Market is projected to hit USD 58.4 million by 2032. The rising prevalence of CVDs, including heart failure and coronary artery disease, is a primary driver. As these conditions become more common, the demand for advanced medical devices, particularly centrifugal blood pumps, surges, underscoring their importance in managing severe cardiac issues and supporting heart surgery patients.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing prevalence of cardiovascular diseases
      • 3.2.1.2 Technological advancements in centrifugal blood pumps
      • 3.2.1.3 Growing investment in cardiovascular research and development
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of devices
      • 3.2.2.2 Stringent regulatory scenario
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technology landscape
    • 3.5.1 Core technologies
    • 3.5.2 Adjacent technologies
  • 3.6 Future market trends
  • 3.7 Gap analysis
  • 3.8 Porter's analysis
  • 3.9 PESTLE analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Electrical
  • 5.3 Mechanical

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Short-term support
  • 6.3 Long-term support

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Ambulatory surgical centers
  • 7.4 Specialty clinics
  • 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
    • 8.3.7 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 Abbott Laboratories
  • 9.2 Braile Biomedica
  • 9.3 Getinge AB
  • 9.4 Hugo Sachs Elektronik
  • 9.5 LivaNova PLC
  • 9.6 Medtronic plc
  • 9.7 Senko Medical Instrument Mfg. Co., Ltd.
  • 9.8 Spectrum Medical
  • 9.9 Terumo Corporation